• Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val173Leu (c.517G>T); ClinVar=VCV000376668; Zygosity=Unspecified (PubMed=25275298).
  

PubMed=8001221; DOI=10.1093/carcin/15.12.2683
Yeudall W.A., Crawford R.Y., Ensley J.F., Robbins K.C.
MTS1/CDK4I is altered in cell lines derived from primary and metastatic oral squamous cell carcinoma.
Carcinogenesis 15:2683-2686(1994)

PubMed=7705939; DOI=10.1002/ijc.2910610117
Cardinali M., Pietraszkiewicz H., Ensley J.F., Robbins K.C.
Tyrosine phosphorylation as a marker for aberrantly regulated growth-promoting pathways in cell lines derived from head and neck malignancies.
Int. J. Cancer 61:98-103(1995)

PubMed=9049184; DOI=10.1002/(SICI)1098-2744(199702)18:2<89::AID-MC4>3.0.CO;2-L
Yeudall W.A., Jakus J., Ensley J.F., Robbins K.C.
Functional characterization of p53 molecules expressed in human squamous cell carcinomas of the head and neck.
Mol. Carcinog. 18:89-96(1997)

PubMed=9389571; DOI=10.1002/(SICI)1097-0215(19971114)73:4<551::AID-IJC16>3.0.CO;2-C
Patel V., Jakus J., Harris C.M., Ensley J.F., Robbins K.C., Yeudall W.A.
Altered expression and activity of G1/S cyclins and cyclin-dependent kinases characterize squamous cell carcinomas of the head and neck.
Int. J. Cancer 73:551-555(1997)

PubMed=25275298; DOI=10.18632/oncotarget.2417; PMCID=PMC4253406
Martin D., Abba M.C., Molinolo A.A., Vitale-Cross L., Wang Z.-Y., Zaida M., Delic N.C., Samuels Y., Lyons J.G., Gutkind J.S.
The head and neck cancer cell oncogenome: a platform for the development of precision molecular therapies.
Oncotarget 5:8906-8923(2014)